14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LYEL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Lyell Immunopharma, Inc. stock price down 1.57% on Wednesday
(Updated on May 08, 2024)

Buy candidate since May 01, 2024 Gain 7.30% PDF

The Lyell Immunopharma, Inc. stock price fell by -1.57% on the last day (Wednesday, 8th May 2024) from $2.54 to $2.50. During the last trading day the stock fluctuated 4.45% from a day low at $2.47 to a day high of $2.58. The price has fallen in 5 of the last 10 days but is still up by 8.7% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -85 thousand shares and in total, 840 thousand shares were bought and sold for approximately $2.10 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.01% during the next 3 months and, with a 90% probability hold a price between $2.00 and $3.35 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LYEL Signals & Forecast

The Lyell Immunopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.41 and $2.28. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -18.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Lyell Immunopharma, Inc. stock

Lyell Immunopharma, Inc. finds support from accumulated volume at $2.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.110 between high and low, or 4.45%. For the last week, the stock has had daily average volatility of 7.35%.

Our recommended stop-loss: $2.35 (-5.86%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 47 days ago.)

Trading Expectations (LYEL) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect Lyell Immunopharma, Inc. to open at $2.52, and during the day (based on 14 day Average True Range), to move between $2.30 and $2.70, which gives a possible trading interval of +/-$0.199 (+/-7.94%) up or down from last closing price. If Lyell Immunopharma, Inc. takes out the full calculated possible swing range there will be an estimated 15.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.52 (0.80%) than the support at $2.41 (3.60%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Lyell Immunopharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Lyell Immunopharma, Inc. stock to perform well in the short-term.

Current score: 1.019 Buy Candidate Unchanged

Predicted Opening Price for Lyell Immunopharma, Inc. of Thursday, May 9, 2024

Fair opening price May 9, 2024 Current price
$2.52 ( 0.667%) $2.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LYEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.63 5.07 %
R2 2.58 3.39 %
R1 2.56 2.35 %
Current price: 2.50
Support S1 2.47 -1.01 %
S2 2.45 -2.05 %
S3 2.41 -3.73 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.01 20.40 %
R2 2.54 1.60 %
R1 2.52 0.80 %
Current price 2.50
Support S1 2.41 -3.60%
S2 2.40 -4.00%
S3 2.33 -6.80%

FAQ

What is the symbol for Lyell Immunopharma, Inc. Stock and on which exchange is it traded?
The symbol for Lyell Immunopharma, Inc. is LYEL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lyell Immunopharma, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Lyell Immunopharma, Inc. stock to perform well in the short-term.

How to buy Lyell Immunopharma, Inc. Stock?
Lyell Immunopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lyell Immunopharma, Inc. Stock.

What's the current price of Lyell Immunopharma, Inc. Stock?
As of the end of day on the May 08, 2024, the price of an Lyell Immunopharma, Inc. (LYEL) share was $2.50.

What is the 52-week high and low for Lyell Immunopharma, Inc. Stock?
The 52-week high for Lyell Immunopharma, Inc. Stock is $46.28 and the 52-week low is $36.31.

What is the market capitalization of Lyell Immunopharma, Inc. Stock?
As of the May 08, 2024, the market capitalization of Lyell Immunopharma, Inc. is 647.54M.

When is the next earnings date for Lyell Immunopharma, Inc.?
The upcoming earnings date for Lyell Immunopharma, Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Lyell Immunopharma, Inc.

Lyell Immunopharma. Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ... LYEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT